Join to View Full Profile
3400 Spruce Street8 Penn TowerPhiladelphia, PA 19104
Phone+1 215-662-6932
Fax+1 205-934-5155
Dr. Bar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 2006 - 2009
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2002 - 2005
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2002
Certifications & Licensure
PA State Medical License 2011 - 2026
AL State Medical License 2006 - 2011
VA State Medical License 2002 - 2006
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States Start of enrollment: 2017 Dec 27
- COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. Start of enrollment: 2020 May 13
Publications & Presentations
PubMed
- Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 Antibodies.Marie Høst Pahus, Yu Zheng, Maxine Olefsky, Jesper Damsgaard Gunst, Pablo Tebas
The Journal of Infectious Diseases. 2025-02-20 - Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques.Ellie Mainou, Stella J Berendam, Veronica Obregon-Perko, Emilie A Uffman, Caroline T Phan
Epidemics. 2024-09-01 - Assessing the impact of autologous neutralizing antibodies on rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaques.Ellie Mainou, Stella J Berendam, Veronica Obregon-Perko, Emilie A Uffman, Caroline T Phan
Biorxiv. 2024-06-03
Journal Articles
- HIV-1 Latent Reservoir Size and Diversity Are Stable Following Brief Treatment InterruptionRobert F. Siliciano, Jonathan Z. Li, Katharine J. Bar, James Hoxie, Pablo Tebas, The Journal of Clinical Investigation
Press Mentions
FDA Approves COVID Antibody Treatment for ImmunocompromisedAugust 3rd, 2021- Regeneron’s Antibody Drug Can Help Prevent COVID-19 from Spreading Among Household MembersApril 12th, 2021
- FDA’s Emergency Authorization for Convalescent Plasma in Covid-19 Sparks ControversyAugust 24th, 2020
- Join now to see all
Grant Support
- Determining the effects of broadly neutralizing antibodies at antiretroviral therapy initiationUNIVERSITY OF PENNSYLVANIA2023–2027
- Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1UNIVERSITY OF PENNSYLVANIA2022–2027
- Characterizing the viral and host effector mechanisms that govern HIV-1 reboundUNIVERSITY OF PENNSYLVANIA2021–2026
- Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editingUNIVERSITY OF PENNSYLVANIA2021–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
